Sign In
Buy LLY
$1,116.11
-5.06 (-0.451%)
At Close: Aug 04, 2026
Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%
12:18pm, Thursday, 09'th Jul 2026
The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is the default healthcare allocation for millions of investors, and for good reason.
Jim Cramer Says Biotech is The Hottest Group in The Market Right Now
11:35am, Thursday, 09'th Jul 2026
CNBC's Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter.
Here's Why Eli Lilly (LLY) is a Strong Growth Stock
10:46am, Thursday, 09'th Jul 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry
08:46am, Thursday, 09'th Jul 2026
Novo Nordisk regains competitive ground in obesity with the strong launch of the Wegovy pill, reversing some of the recent underperformance against Eli Lilly. NVO's Wegovy pill outpaces Eli Lilly's Fo
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?
08:15am, Thursday, 09'th Jul 2026
VHT offers broad diversification across 429 healthcare holdings, while PPH concentrates on 26 drugmakers for higher growth potential.
Analyses across Kisunla (donanemab-azbt) trials providing further insights into the benefit-risk profile from long-term extension data New data compares the diagnostic performance of P-tau217 blood te
Strong LLY News Boosts Active Healthcare ETF GDOC
02:18pm, Wednesday, 08'th Jul 2026
Healthcare and technology provide an intriguing contrast. Many healthcare stocks are traditionally known for their more defensive uses in portfolios.
Is It Too Late to Buy Eli Lilly?
02:10pm, Wednesday, 08'th Jul 2026
Eli Lilly leads the high-growth weight loss drug market. The company's weight loss portfolio generated more than $12 billion in revenue in the latest quarter.
The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
12:36pm, Wednesday, 08'th Jul 2026
Markets are being tested again. The AI trade has spent the past several weeks under real pressure, with memory, semiconductor, and neocloud names selling off hard after an extraordinary first half.
LLY Hits Another Record High: Is the Stock Too Expensive to Buy Now?
11:11am, Wednesday, 08'th Jul 2026
Eli Lilly hits another record high as confidence grows in its obesity and diabetes portfolio, with Wall Street still seeing upside despite the rich valuation.
This $1,200 Stock Could Be the Next Massive Stock Split Opportunity
08:42am, Wednesday, 08'th Jul 2026
$8.662 billion. That is what Mounjaro alone generated for Eli Lilly (NYSE:LLY | LLY Price Prediction) in the first quarter of 2026, a single product, a single quarter, up 125% year over year.
Top 50 High-Quality Dividend Growth Stocks For July 2026
07:42am, Wednesday, 08'th Jul 2026
I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation and future return potential. Year-to-date through June, the investable univer
Why Eli Lilly Stock Climbed to a Record High Today
09:53pm, Tuesday, 07'th Jul 2026
Eli Lilly's shareholders are in store for even more gains, according to a respected investment bank. The drugmaker is poised to profit from the rapid growth of the global obesity treatment market.
Everyone Thinks the Eli Lilly Story Is Played Out. Cramer Thinks They're Dead Wrong
02:55pm, Tuesday, 07'th Jul 2026
Drug stocks got hit hard on Monday in what Jim Cramer called a “vicious rotation,” and the selloff looked like the usual crowded-trade unwind.
U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend
02:15pm, Tuesday, 07'th Jul 2026
Eli Lilly and Intuitive Surgical are top players in their respective corners of the healthcare market. Both companies are highly innovative and boast attractive long-term growth opportunities.
